Comparative efficacy of Sorafenib, and Lenvatinib in Hepatocellular Carcinoma: a meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
1. Verfasser: | Monayem, Kazi Fahim |
---|---|
Weitere Verfasser: | Momtaz, Tanisha |
Format: | Abschlussarbeit |
Sprache: | English |
Veröffentlicht: |
Brac University
2024
|
Schlagworte: | |
Online Zugang: | http://hdl.handle.net/10361/23930 |
Ähnliche Einträge
-
Elucidating the functional roles of bidirectionally transcribed genes in immunobiology of cancers
von: Ahmad, Sheikh Shafin
Veröffentlicht: (2021) -
Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
von: Shawn, Ibna Hasan
Veröffentlicht: (2024) -
Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
von: Shobnam, Sohana
Veröffentlicht: (2024) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
von: Paul, Pulock
Veröffentlicht: (2024) -
An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
von: Hasan, Amit
Veröffentlicht: (2024)